August 26, 2009

PPAR-g agonists have potential therapeutic role in gastric carcinoma?

Recently, the potential of PPAR-γ as a target for the prevention and treatment of cancer has been widely studied. However, the potential therapeutic role of PPAR-γ agonists has been questioned, based on contradictory results. Studies using animal models of colon cancer found that PPAR-γ agonists increased the development of colon tumors.

This contradictory result was supplemented by a recent report using transgenic mice expressing a constitutive active form of PPAR-γ in which showed that PPAR-γ signaling accelerated tumor development in mammary glands. The actual role of PPAR-γ in cancer has been complicated by recent findings that PPAR-γ agonists affect cancer cells independently of PPAR-γ, and silencing of PPAR-γ and a PPAR-γ antagonist inhibit cancer cell growth. To date, the role of PPAR-γ in gastric carcinogenesis remains unclear.

A research article to be published on August 21, 2009 in the addresses this question. A study from China found that PPAR-γ may be involved in gastric carcinogenesis, and that the PPAR-γ agonist 15d-PGJ2 may inhibit the growth of human gastric carcinoma MGC803 cell by inducing apoptosis and G1/G0 arrest, involving survivin, Skp2 and p27, but via a PPAR-γ-independent pathway.

The study showed that the PPAR-γ agonist 15d-PGJ2 inhibited growth of cultured gastric MGC803 cells, and demonstrated that the PPAR-γ antagonist GW9662 did not block this effect of 15d-PGJ2 and that 2.5 μM GW9662 inhibited growth of MGC803 cells. Furthermore, PPAR-γ siRNA remarkably inhibited the growth of MGC803 cells.

These results indicated that 15d-PGJ2 inhibited growth of cultured gastric carcinoma MGC803 cells by a PPAR-γ-independent pathway. These results also suggest that PPAR-γ agonists could be useful in the chemoprevention or chemotherapy of gastric malignancies.

More information: Ma XM, Yu H, Huai N. Peroxisome proliferator-activated receptor-g is essential in the pathogenesis of gastric carcinoma. World J Gastroenterol 2009; 15(31): 3874-3883; www.wjgnet.com/1007-9327/15/3874.asp

Source: World Journal of Gastroenterology (news : web)

Citation: PPAR-g agonists have potential therapeutic role in gastric carcinoma? (2009, August 26) retrieved 18 April 2024 from https://medicalxpress.com/news/2009-08-ppar-g-agonists-potential-therapeutic-role.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

A potential drug for liver carcinoma
 shares

Feedback to editors
Researchers discover new therapeutic target for non-small cell lung cancer

5 hours ago
Immune cells carry a long-lasting 'memory' of early-life pain

6 hours ago
Cannabis legalization and rising sales have not contributed to increase in substance abuse, study finds

6 hours ago
No negative impact from prolonged eye patching on child's development or family stress levels

6 hours ago
COVID-19 booster immunity lasts much longer than primary series alone, study shows

6 hours ago
Study finds that human neuron signals flow in one direction

7 hours ago
A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

8 hours ago
Scientists identify airway cells that sense aspirated water and acid reflux

8 hours ago
Environment may influence metacognitive abilities more than genetics

8 hours ago
Contracting RSV before age two can cause long-term lung changes and impairment

8 hours ago
Load comments (0)